Skip to main content

Healthcare & Biotech

RCM Market to Nearly Double to $132 Billion by 2031 as AI Reshapes Billing

Image
RCM Market to Nearly Double to $132 Billion by 2031 as AI Reshapes Billing

Delray Beach, Fla. – – September 15, 2026 -- The global Revenue Cycle Management market is projected to reach USD 132.06 billion by 2031, up from USD 73.61 billion in 2026, expanding at a compound annual growth rate of 12.4%, according to MarketsandMarkets.

North America controls 40% of the RCM market as denial rates push AI adoption

North America held a 40.0% share of the global RCM market in 2025, driven by a fragmented US payer landscape and rising claim denial rates that are pushing hospital networks toward AI-assisted coding and predictive denial analytics. Small and medium-sized enterprises are the fastest-growing enterprise segment, expanding at a 13.0% CAGR, while on-premises deployment still commands 56.4% of the market despite the shift toward cloud platforms.

NYU Langone Names Sean Berry Vice Chair of Radiation Oncology Physics

Image
NYU Langone Names Sean Berry Vice Chair of Radiation Oncology Physics

New York – September 15, 2026 -- NYU Langone Health's Perlmutter Cancer Center has named Sean L. Berry, PhD, vice chair of physics and dosimetry in its Department of Radiation Oncology, recruiting a 20-year veteran of Memorial Sloan Kettering Cancer Center to lead treatment-planning quality and safety programs.

Berry moves from a regional physicist role overseeing multi-site radiation oncology operations

Before joining NYU Langone, Berry served as regional lead physicist and associate attending physicist at Memorial Sloan Kettering Cancer Center, managing clinical physics operations across outpatient sites in Westchester County, New York, and Bergen County, New Jersey. His duties included supervising faculty physicists, staff physicists and dosimetrists, regulatory readiness, accreditation activities, budget oversight, linear accelerator commissioning and standardizing radiation oncology practice across multiple locations.

Noom CEO Proposes 'Habit Window' Framework to Fix GLP-1 Dropout Rates

Toronto – September 15, 2026 -- A new viewpoint paper published in the Journal of Medical Internet Research argues that GLP-1 weight-loss drugs fail long-term without paired digital behavioral coaching, citing high patient dropout and rapid weight regain as persistent industry problems. The paper, authored by Noom CEO Geoff Cook, introduces a "habit window hypothesis" and calls for a formal research agenda to test whether digital health apps can extend the durability of pharmacological weight loss.

SQAIRZ Launches Medical Division to Tackle $80B Fall-Risk Crisis

Windham, N.H. – September 15, 2026 -- SQAIRZ, a biomechanically driven performance footwear company, has launched SQAIRZ Medical, a new division targeting fall risk among aging adults through a combined footwear and clinical assessment platform.

Fall injuries cost the U.S. healthcare system more than $80 billion annually

One in four U.S. adults over age 65 falls at least once a year, a figure that rises to one in two for adults over 80, according to SQAIRZ. The company positions SENTRX, its purpose-built Balance & Stability footwear, as the centerpiece of a broader clinical framework aimed at reducing that risk.

Saudi Arabia Nominates Dr Hanan Balkhy for WHO Director-General

Image
Saudi Arabia Nominates Dr Hanan Balkhy for WHO Director-General

Riyadh – September 15, 2026 -- Dr Hanan H. Balkhy, WHO Regional Director for the Eastern Mediterranean, has launched her candidacy for WHO Director-General after being nominated by the Kingdom of Saudi Arabia, pledging to build "a WHO the world can count on."

Saudi Arabia backs a 30-year public health veteran for WHO's top post

Dr Balkhy, trained in Saudi Arabia and the United States, has spent more than three decades in clinical medicine, academic research and international public health leadership. She currently oversees WHO operations across 22 Member States and more than 750 million people as Regional Director for the Eastern Mediterranean, and previously served as WHO's first Assistant Director-General for Antimicrobial Resistance and as a member of the Organization's Global Policy Group.

CytoSorbents Execs to Present at H.C. Wainwright Investor Conference

Image
CytoSorbents Execs to Present at H.C. Wainwright Investor Conference

Princeton, N.J. – – September 15, 2026 -- CytoSorbents Corporation (NASDAQ: CTSO) will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York City from September 14–16, 2026, as the blood-purification device maker seeks to update investors on its regulatory pipeline and path to profitability.

CEO and CFO to join fireside chat on September 14

Dr. Phillip Chan, Chief Executive Officer, and Peter Mariani, Chief Financial Officer, will join Sean Lee, Vice President of Equity Research at H.C. Wainwright, for a fireside chat at 11:30 a.m. EDT at the Lotte New York Palace Hotel. The two executives will also hold scheduled one-on-one meetings with investors during the three-day event. A webcast replay will remain archived for up to 90 days on the company's investor relations site.

Munich Pharmacy Roadshow Draws 3,000 Ahead of German Apothekertag

Image
Munich Pharmacy Roadshow Draws 3,000 Ahead of German Apothekertag

Munich – September 15, 2026 -- Up to 3,000 registered pharmacists, pharmacy technicians (PTA) and pharmacy clerks (PKA) are set to attend the APOTHEKENTOUR in Munich on September 12-13, the event's second stop after Berlin drew more than 2,500 attendees and a 15% year-on-year increase in visitors.

Munich stop packs 170 talks and pharma-partner cases into one weekend

The Munich edition, powered by APOTHEKE ADHOC and PTA IN LOVE, will feature more than 170 lectures, several live talks and new product showcases connecting attendees directly with pharmaceutical industry partners. The event is scheduled deliberately the weekend before the Deutscher Apothekertag, where Health Minister Carsten Linnemann (CDU) is expected to address the sector's political future.

Donate Life America Names Madison Walter-Garcia as Next President & CEO

Image
Donate Life America Names Madison Walter-Garcia as Next President & CEO

Richmond, Va. – September 15, 2026 -- Donate Life America (DLA) has named Madison Walter-Garcia, MPH, CHES, as its next President & CEO, effective September 21, succeeding David Fleming after more than 30 years of leadership.

Walter-Garcia Brings Nearly a Decade of CDC Partnership Experience to DLA

Walter-Garcia spent nearly ten years at the Centers for Disease Control and Prevention (CDC), most recently as Associate Director for Partnerships in the Division of Foodborne, Waterborne, and Environmental Diseases. She built partnership programs from the ground up, cultivated relationships with more than 1,000 stakeholders, and led a gift portfolio through the CDC Foundation exceeding $30 million.

NetDragon Funds HKUST Medical Technology Professorship

Image
NetDragon Funds HKUST Medical Technology Professorship

Hong Kong – September 15, 2026 -- NetDragon Websoft Holdings Limited (Hong Kong Stock Code: 777) has agreed to fund a new "NetDragon Professorship in Medical Technology" at The Hong Kong University of Science and Technology (HKUST), targeting research at the intersection of engineering and medicine.

NetDragon commits funding to back a distinguished HKUST engineering scholar

The professorship will be conferred on a scholar from HKUST's School of Engineering in recognition of research contributions, with the goal of accelerating breakthroughs in precision medicine and digital health. The signing ceremony took place on the HKUST campus, witnessed by HKUST President Prof. Nancy Ip and NetDragon Chairman and Executive Director Dr. Liu Dejian. The agreement was formally signed by Prof. Charles Ng, HKUST's Vice-President for Institutional Advancement, and Dr. Simon Leung, NetDragon's Vice Chairman and Executive Director.

BPI Convenes Pharmacy, Insurer, Politics Panel on Prevention at Expopharm

Image
BPI Convenes Pharmacy, Insurer, Politics Panel on Prevention at Expopharm

Berlin – – September 15, 2026 -- The Bundesverband der Pharmazeutischen Industrie (BPI) will bring together four senior stakeholders from pharmacy, politics, health insurance and the pharmaceutical industry on September 16, 2026, to debate how prevention can be scaled across Germany's healthcare system.

BPI schedules prevention panel for expopharm networking breakfast

The discussion, titled "Prävention als Chance für unser Gesundheitssystem," takes place at 9:00 a.m. (doors open 8:30 a.m.) in Hall A3 of the pharmaworld area at expopharm, as part of the BPI's networking breakfast.

Pharmacist chamber pushes for pharmacies as broader health navigators

Franziska Scharpf, Vice President of the Bundesapothekerkammer, argues that pharmacies should expand their role as health navigators through screenings, pharmaceutical counseling, vaccination services and guided self-medication.